Title: Wolfgang Hiddemann: Innovator in Cancer Treatment
Introduction
Wolfgang Hiddemann is an accomplished inventor based in Starnberg, Germany. He is currently associated with Lindis Biotech GmbH, where he focuses on innovative solutions for cancer treatment. Although he does not hold any granted patents, his work in the field of bispecific antibodies is noteworthy.
Latest Patent Applications
Hiddemann's latest patent application is titled "Subcutaneously Administered Bispecific Antibodies for Use in the Treatment of Cancer." This invention relates to the use of T cell redirecting, bispecific, particularly trifunctional, antibodies for treating cancer. The application highlights that the antibody is administered via the subcutaneous route, which reduces the release of proinflammatory cytokines while simultaneously suppressing the release of inhibitory cytokines. This innovative treatment approach may also be combined with other anti-cancer drugs for enhanced efficacy.
Conclusion
Wolfgang Hiddemann's contributions to the field of cancer treatment through bispecific antibodies demonstrate his commitment to advancing medical science. His innovative ideas have the potential to significantly impact cancer therapy in the future.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.